Tumor genomic profiling (TGP) is used in oncology practice to optimize cancer treatment
and improve survival rates. However, TGP is underutilized among Black and African …

Tumor genomic profiling (TGP) identifies genetic targets for precision cancer treatments. The
complexity of TGP can expose gaps in oncologists' skills, complicating test interpretation and …

PURPOSE Social determinants of health, such as rurality, income, and education, may
widen health disparities by driving variation in patients' knowledge and perceptions of …

PURPOSE Racial and ethnic disparities in genetic awareness (GA) can diminish the impact
of personalized cancer treatment and risk assessment. We assessed factors predictive of GA …

Purpose Medical distrust has been identified as a persistent barrier to medical care, affecting
preventative screening, treatment uptake, and treatment adherence. Despite this, little …

PURPOSE Large-panel genomic tumor testing (GTT) is an emerging technology that
promises to make cancer treatment more precise. Because GTT is novel and complex …

Cancer‐related genetic testing (hereafter CGT) has transformed cancer prevention,
treatment, and care. Researchers debate whether diffusion and use of genetic testing will …

Background Genetic testing can help determine the risk of many cancers and guide cancer
prevention and treatment plans. Despite increasing concern about disparities in precision …

The senseless killings of George Floyd, Ahmaud Arbery, Breonna Taylor, and countless
others have led to a national reckoning on institutional racism. In medicine, race has long …

The study objective was to examine bivariate and multivariate associations among worry,
perceptions, attitudes, sociodemographics, and uptake of cancer-related germline genetic …